SINTX TECHNOLOGIES INC

SINTNASDAQ

🏆 #4494 by market capEarnings Nov 12US Equity

$1.64▼ $0.12 (−7.34%)

Live

1h▼ 1.8%

24h▼ 7.3%

7d▼ 5.7%

14d▲ 10.1%

30d▲ 4.1%

1y▼ 44.4%

🏦Market Cap

$10M

Small Cap

📈Revenue Growth (YoY)

-60.0%

Declining

📊Gross Margin

46.8%

Healthy

💵FCF Margin

—

⚖️P/S Ratio

10.9x

Elevated

Otter Score

Weak

Trading Snapshot

Day Range: $1.63 – $1.66
52-Week Range: $1.40 – $6.78
Volume: $2.87B
Avg Volume: $2.99B
Shares Outstanding: 6.2M
Next Earnings: Sep 12, 2026

Fundamentals Snapshot

Annual Revenue: $1M
Last Q Revenue: $452,000
P/E Ratio: —
P/S Ratio: 10.9x
EPS (TTM): $-3.39
Dividend Yield: —

Why Investors Own SINT

✓High-growth profile — revenue up -5.2% YoY with expanding US Equity exposure.
✓Healthy economics — 65% gross margin and 30% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$1M▼ −8.6% YoY

Gross Margin (TTM)

65.2%▲ +1.9% YoY

Operating Income (TTM)

$263,662▼ −8.6% YoY

Free Cash Flow (TTM)

$300,310▼ −8.6% YoY

About SINTX TECHNOLOGIES INC

Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.

🦦